Original document(10 pages)  中文版
    Disclosed is a Chinese traditional medicine for treating osteoporosis, which is prepared from drynaria 15-25 parts, pilose asiabell root 15-25 parts, dipsacus root 15-25 parts, oyster 25-35 parts, tortoise shell 5-15 parts, and root of red rooted saliva 15-25 parts through the steps of disintegrating, water immersing, watering and boiling, filtering, concentrating, charging tortoise shell fines and mixing homogeneously, charging starch gum, obtaining granules and drying, finally carrying out dressing.
Application Number
申请号
200510009771 Application Date
申请日
2005.02.28
Title 名称 Chinese traditional medicine for treating osteoporosis
Publication Number
公开号
1827123 Publication Date
公开日
2006.09.06
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K36/53,A61K9/16,A61P19/10,A61K35/56
Applicant(s) Name
申请人
Zhang Guangmei
Address 地址 150001
Inventor(s) Name 发明人 Zhang Guangmei
Attorney & Agent 代理人

  
Dripping pills of herba lamiophlomis rotatae and method for preparing the same
Compound orally disintegrating tablet of red sage root, its preparation method and quality control method
Chinese medicinal composition for treating viral infection of upper respiratory tract and preparing process thereof
Extraction method and technique of olive leaf extract
Vaginal administered medicament with honeysuckle, baikal skullcap root and forsythia fruit and method for preparing the same
Moisture-resisting toxin-removing Chinese medicinal spray
Formulation prepared from effective parts of red sage root and moutan bark, its compound preparation method and medical application
Medicinal composition for treating dysmenorrhea and preparation method thereof
Medicine for treating cholestasis and hepatic fibrosis and method for preparing the same
Medicine for treating dermatopathy and its preparing process
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.